Literature DB >> 11508450

Successful treatment of patients with systemic lupus erythematosus by immunoadsorption with a C1q column: a pilot study.

B Pfueller1, K Wolbart, A Bruns, G R Burmester, F Hiepe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11508450     DOI： 10.1002/1529-0131(200108)44:8<1962::AID-ART335>3.0.CO;2-R

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  11 in total

Review 1.  Treatment of severe proliferative lupus nephritis: the current state.

Authors:  C C Mok; R W S Wong; K N Lai
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 2.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

Review 3.  Antibodies against C1q in patients with systemic lupus erythematosus.

Authors:  Marten Trendelenburg
Journal:  Springer Semin Immunopathol       Date:  2005-11-11

4.  Rapid reduction of antibodies and improvement of disease activity by immunoadsorption in Chinese patients with severe systemic lupus erythematosus.

Authors:  Jinxian Huang; Guoxiang Song; Zhihua Yin; Weizhen He; Lijun Zhang; Weihong Kong; Zhizhong Ye
Journal:  Clin Rheumatol       Date:  2016-08-03       Impact factor: 2.980

5.  C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Authors:  P Horák; Z Hermanová; J Zadrazil; H Ciferská; M Ordeltová; L Kusá; M Zurek; T Tichý
Journal:  Clin Rheumatol       Date:  2005-11-26       Impact factor: 2.980

6.  Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy.

Authors:  Yoshitaka Iwazu; Tetsu Akimoto; Sayoko Izawa; Makoto Inoue; Shigeaki Muto; Yasuhiro Ando; Kana Iwazu; Noriyoshi Fukushima; Wako Yumura; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2012-02-18       Impact factor: 2.801

7.  Retrospective study of plasma exchange in children with systemic lupus erythematosus.

Authors:  Elizabeth C Wright; Kjell Tullus; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2004-08-05       Impact factor: 3.714

Review 8.  Novel Approaches to Therapy for SLE.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

9.  Anti-C1q autoantibodies, novel tests, and clinical consequences.

Authors:  Michael Mahler; Rosanne A van Schaarenburg; Leendert A Trouw
Journal:  Front Immunol       Date:  2013-05-14       Impact factor: 7.561

Review 10.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.